These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24231729)

  • 21. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
    Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
    Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy.
    Lonardo E; Hermann PC; Mueller MT; Huber S; Balic A; Miranda-Lorenzo I; Zagorac S; Alcala S; Rodriguez-Arabaolaza I; Ramirez JC; Torres-Ruíz R; Garcia E; Hidalgo M; Cebrián DÁ; Heuchel R; Löhr M; Berger F; Bartenstein P; Aicher A; Heeschen C
    Cell Stem Cell; 2011 Nov; 9(5):433-46. PubMed ID: 22056140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of pancreatic cancer stem cells by flow cytometry and their biological characteristics.
    Li D; Su D; Xue L; Liu Y; Pang W
    Int J Clin Exp Pathol; 2015; 8(9):11218-23. PubMed ID: 26617845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual blocking of mTor and PI3K elicits a prodifferentiation effect on glioblastoma stem-like cells.
    Sunayama J; Sato A; Matsuda K; Tachibana K; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C
    Neuro Oncol; 2010 Dec; 12(12):1205-19. PubMed ID: 20861085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TBK1 regulates prostate cancer dormancy through mTOR inhibition.
    Kim JK; Jung Y; Wang J; Joseph J; Mishra A; Hill EE; Krebsbach PH; Pienta KJ; Shiozawa Y; Taichman RS
    Neoplasia; 2013 Sep; 15(9):1064-74. PubMed ID: 24027431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of cancer stem cell properties via mTOR signaling pathway inhibition by rapamycin in nasopharyngeal carcinoma.
    Yang C; Zhang Y; Zhang Y; Zhang Z; Peng J; Li Z; Han L; You Q; Chen X; Rao X; Zhu Y; Liao Z
    Int J Oncol; 2015 Sep; 47(3):909-17. PubMed ID: 26202311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells.
    Xue ZX; Zheng JH; Zheng ZQ; Cai JL; Ye XH; Wang C; Sun WJ; Zhou X; Lu MD; Li PH; Cai ZZ
    World J Surg Oncol; 2014 Dec; 12():404. PubMed ID: 25551472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between telomerase and mTOR pathway in cancer stem cells.
    Dogan F; Biray Avci C
    Gene; 2018 Jan; 641():235-239. PubMed ID: 29074462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective targeting of human colon cancer stem-like cells by the mTOR inhibitor Torin-1.
    Francipane MG; Lagasse E
    Oncotarget; 2013 Nov; 4(11):1948-62. PubMed ID: 24185040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer stem cells: a novel paradigm for cancer prevention and treatment.
    Subramaniam D; Ramalingam S; Houchen CW; Anant S
    Mini Rev Med Chem; 2010 May; 10(5):359-71. PubMed ID: 20370703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin.
    Quan MF; Xiao LH; Liu ZH; Guo H; Ren KQ; Liu F; Cao JG; Deng XY
    World J Gastroenterol; 2013; 19(43):7680-95. PubMed ID: 24431896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells.
    Matsumoto K; Arao T; Tanaka K; Kaneda H; Kudo K; Fujita Y; Tamura D; Aomatsu K; Tamura T; Yamada Y; Saijo N; Nishio K
    Cancer Res; 2009 Sep; 69(18):7160-4. PubMed ID: 19738050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
    Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S
    J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclopamine sensitizes glioblastoma cells to temozolomide treatment through Sonic hedgehog pathway.
    Carballo GB; Matias D; Ribeiro JH; Pessoa LS; Arrais-Neto AM; Spohr TCLSE
    Life Sci; 2020 Sep; 257():118027. PubMed ID: 32622951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells.
    Sunayama J; Matsuda K; Sato A; Tachibana K; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C
    Stem Cells; 2010 Nov; 28(11):1930-9. PubMed ID: 20857497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
    Ma L; Lai D; Liu T; Cheng W; Guo L
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual inhibition of PI3K and mTOR signaling pathways decreases human pancreatic neuroendocrine tumor metastatic progression.
    Djukom C; Porro LJ; Mrazek A; Townsend CM; Hellmich MR; Chao C
    Pancreas; 2014 Jan; 43(1):88-92. PubMed ID: 24263107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma.
    Bar EE; Chaudhry A; Lin A; Fan X; Schreck K; Matsui W; Piccirillo S; Vescovi AL; DiMeco F; Olivi A; Eberhart CG
    Stem Cells; 2007 Oct; 25(10):2524-33. PubMed ID: 17628016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of baicalein on pancreatic cancer stem cells via modulation of sonic Hedgehog pathway.
    Song L; Chen X; Wang P; Gao S; Qu C; Liu L
    Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):586-596. PubMed ID: 29697746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer.
    Nomura A; Banerjee S; Chugh R; Dudeja V; Yamamoto M; Vickers SM; Saluja AK
    Oncotarget; 2015 Apr; 6(10):8313-22. PubMed ID: 25829252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.